China (Mainland)
Selexipag Intermediate 4 CAS NO.18591-57-6
- FOB Price: USD: 1.00-1.00 /Kilogram Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: L/C,T/T
- Available Specifications:
98%(1-1000)Kilogram98%(1-10)Kilogram
- Product Details
Keywords
- 5,6-DIPHENYLPYRAZIN-2-OL
- CAS No.18591-57-6
- 98%
Quick Details
- ProName: Selexipag Intermediate 4
- CasNo: 18591-57-6
- Molecular Formula: C16H12N2O
- Appearance: light yellow powder
- Application: Used in chemical field CAS 18591-57-6
- DeliveryTime: 15days
- PackAge: The normal temperature airtight save
- Port: Nanjing
- ProductionCapacity: 5 Kilogram/Month
- Purity: 98%
- Storage: At room temperature away from light ai...
- Transportation: According to the customer request
- LimitNum: 1 Gram
- Impurity: NMT 2%
Superiority
2, Fast delivery
3, COA/HPLC/HNMR available
4, Reliable provider & satisfactory service
Pls contact with us freely for getting detailed product specifications, product tech. data sheet, COA and MSDS, prices, delivery time and payment terms.
Core-Tech exported this product to many countries and regions at best price in China. If you are looking for the product's supplier CAS: 42042-71-7,475086-75-0,475084-96-9,475085-57-5 in China, Core-Tech is your best choice.
Details
ABOUT US
Nanjing CoreTech biomedical Co,.Ltd. which is controlled by the Nanjing New Industrial Investment Group was founded in 2002.The company which takes the aim at industrialization is a biomedical research institute. It has two core businesses which are API and intermediate research and industrialization, biomedical R and D outsourcing.
In the aspect of API and pharmaceutical intermediates, the company has successfully developed more than 120 new drugs，of which 70 can be long-term stably supplied to domestic and foreign customers. The quality of Products achieve to international standards such as European pharmacopoeia standard, American pharmacopoeia standard. In the aspect of biomedical R and D outsourcing, the company has developed 4 innovative medicines and got 26 drug registration approvals of CFDA.
The company with 41 patents at home and abroad won 50 science projects from government. It is the "International cooperation Demonstration base", " Biomedical science and Technology public service platform of Jiangsu Province"," Enterprise Academician workstation of Jiangsu Province " etc.
The R & D and incubation center of the company is 26,000 square meters. It has built a drug development, life sciences technology and CMO platform. The professional R and D team contains many Ph.D.S and overseas high-level talents, they are specialist in drug discovery, research, registration, clinical CRO and so on. It can provide more than 500 professional services for the biomedical and related fields.
In recent years, the company constantly enriched international technology transfer, university-industry cooperation, high-level innovative entrepreneurial talent and R & D outsourcing resourses. Carrying out industry-college-research cooperation with Chen Yuanhong academician of Nanjing University, Zhang Yaoming academician of Southeast University and establishing strategic cooperation with Cels Inc, Technology links2 Inc of England, XBL Inc of American, Xiansheng Pharmaceutical Co.,Ltd, Yangzijiang Pharmaceutical Co.,Ltd and so on.